Inducible nitric oxide synthase (inos) and heart failure

Nutrition and Heart Disease: Causation and Prevention

Volumn , Issue , 2003, Pages 333-350

  Yang, Bo ^a   Larson, Douglas F ^a   Watson, Ronald R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646413542     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (111)

1. Jugdutt, B.I. 2002. Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail.Rev. 7, 391.
2. Jugdutt, B.I. 2002. Nitric oxide in heart failure: friend or foe. Heart Fail. Rev. 7, 385.
3. Denninger, J.W. and M.A. Marietta. 1999. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta. 1411, 334.
4. Xie, Q.W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase 2. J. Biol. Chem. 269, 4705.
5. Sanders, D.B., D.F. Larson, C. Jablonowski, and L. Olsen. 1999. Differential expression of inducible nitric oxide synthase in septic shock. J. Extracoporeal Tech. 31, 118.
6. Stoclet, J.C., B. Muller, K. Gyorgy, R. Andriantsiothaina, and A.L. Kleschyov. 1999. The inducible nitric oxide synthase in vascular and cardiac tissue. Eur. J. Pharmacol. 375, 139.
7. Lowenstein, C.J., E.W. Alley, P. Raval, A.M. Snowman, S.H. Snyder, S.W. Russell, and W.J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90, 9730.
8. Xie, Q.W., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177, 1779.
9. Nunokawa, Y., N. Ishida, and S. Tanaka. 1994. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem. Biophys. Res. Commun. 200, 802.
10. Martin, E., C. Nathan, and Q.W. Xie. 1994. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 180, 977.
11. Liang, B., Z. Zhang, P. Inserra, S. Jiang, J. Lee, A. Garza, J.J. Marchalonis, and R.R. Watson. 1998. Injection of T-cell receptor peptide reduces immunosenescence in aged C57BL/6 mice. Immunology. 93, 462.
12. Cernadas, M.R., D.M. Sanchez, M. Garcia-Duran, F. Gonzalez-Fernandez, I. Millas, M. Monton, J. Rodrigo, L. Rico, P. Fernandez, T. de Frutos, J.A. Rodriguez-Feo, J. Guerra, C. Caramelo, S. Casado, and F. Lopez. 1998. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ. Res. 83, 279.
13. Haywood, G.A., P.S. Tsao, H.E. der Leyen, M.J. Mann, PJ. Keeling, P.T. Trindade, N.P. Lewis, C.D. Byrne, P.R. Rickenbacher, N.H. Bishopric, J.P. Cooke, W.J. McKenna, and M.B. Fowler. 1996. Expression of inducible nitric oxide synthase in human heart failure [Comments]. Circulation. 93, 1087.
14. Vejlstrup, N.G., A. Bouloumie, S. Boesgaard, C.B. Andersen, J.E. Nielsen-Kudsk, S.A. Mortensen, J.D. Kent, D.G. Harrison, R. Busse, and J. Aldershvile. 1998. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J. Mol. Cell Cardiol. 30, 1215.
15. Preiser, J.C., P. Lejeune, A. Roman, E. Carlier, D. De Backer, M. Leeman, R.J. Kahn, and J.L. Vincent. 1995. Methylene blue administration in septic shock: a clinical trial. Crit. Care Med. 23, 259.
16. Rees, D.D., J.E. Monkhouse, D. Cambridge, and S. Moncada. 1998. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br. J. Pharmacol. 124, 540.
17. Panas, D., F.H. Khadour, C. Szabo, and R. Schulz. 1998. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide- dependent mechanism. Am. J. Physiol. 275, H1016.
18. Wu, C.C., H. Ruetten, and C. Thiemermann. 1996. Comparison of the effects of aminoguanidine and N omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur. J. Pharmacol. 300, 99.
19. Afulukwe, I.F., R.I. Cohen, G.A. Zeballos, M. Iqbal, and S.M. Scharf. 2000. Selective NOS inhibition restores myocardial contractility in endotoxemic rats; however, myocardial NO content does not correlate with myocardial dysfunction. Am. J. Respir. Crit. Care Med. 162, 21.
20. Ullrich, R., M. Scherrer-Crosbie, K.D. Bloch, F. Ichinose, H. Nakajima, M.H. Picard, W.M. Zapol, and Z.M. Quezado. 2000. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation. 102, 1440.
21. Szabolcs, M.J., S. Ravalli, O. Minanov, R.R. Sciacca, R.E. Michler, and PJ. Cannon. 1998. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 65, 804.
22. Lewis, N.P., P.S. Tsao, P.R. Rickenbacher, C. Xue, R.A. Johns, G.A. Haywood, L.H. von der, P.T. Trindade, J.P. Cooke, S.A. Hunt, M.E. Billingham, H.A. Valantine, and M.B. Fowler. 1996. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 93, 720.
23. Egi, K., N.E. Conrad, A. Bedynek, P. Ferdinandy, B. Reichart, and S.M. Wildhirt. 2001. Improvement of cardiac allograft function by 1400W, a highly selective inducible nitric oxide synthase inhibitor and superoxide dismutase: role of peroxynitrite. J. Heart Lung Transp. 20, 154.
24. Soto, P.F., C.X. Jia, D.G. Rabkin, J.P. Hart, Y.M. Carter, M.J. Sardo, D.T. Hsu, P.E. Fisher, D.J. Pinsky, and H.M. Spotnitz. 2000. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition. J. Thorac. Cardiovasc. Surg. 120, 39.
25. Pieper, G.M., M. Cooper, C.P. Johnson, M.B. Adams, C.C. Felix, and A.M. Roza. 2000. Reduction of myocardial nitrosyl complex formation by a nitric oxide scavenger prolongs cardiac allograft survival. J. Cardiovasc. Pharmacol. 35, 114.
26. Goren, N., C.P. Leiros, L. Sterin-Borda, and E. Borda. 1998. Nitric oxide synthase in experimental autoimmune myocarditis dysfunction. J. Mol. Cell Cardiol. 30, 2467.
27. Drexler, H., S. Kastner, A. Strobel, R. Studer, O. E. Brodde, and G. Hasenfuss. 1998. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J. Am. Coll. Cardiol. 32, 955.
28. Bartunek, J., A.M. Shah, M. Vanderheyden, and W.J. Paulus. 1997. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation. 95, 90.
29. Hare, J.M., M.M. Givertz, M.A. Creager, and W.S. Colucci. 1998. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation. 97, 161.
30. Saito, T., F. Hu, L. Tayara, L. Fahas, H. Shennib, and A. Giaid. 2002. Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am. J. Physiol. Heart Circ. Physiol. 283, H339.
31. Feng, Q., X. Lu, D.L. Jones, J. Shen, and J.M. Arnold. 2001. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 104, 700.
32. Heger, J., A. Godecke, U. Flogel, M. W. Merx, A. Molojavyi, W. N. Kuhn-Velten, and J. Schrader. 2002. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ. Res. 90, 93.
33. Mungrue, I.N., R. Gros, X. You, A. Pirani, A. Azad, T. Csont, R. Schulz, J. Butany, D.J. Stewart, and M. Husain. 2002. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109, 735.
34. Paulus, W.J. and A.M. Shah. 1999. NO and cardiac diastolic function. Cardiovasc. Res. 43, 595.
35. Paulus, W.J. and J.G. Bronzwaer. 2002. Myocardial contractile effects of nitric oxide. Heart Fail. Rev. 7, 371.
36. Drexler, H. 1999. Nitric oxide synthases in the failing human heart: a doubled-edged sword? Circulation. 99, 2972.
37. Kojda, G. and D. Harrison. 1999. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43, 562.
38. Kojda, G. and K. Kottenberg. 1999. Regulation of basal myocardial function by NO [Comments]. Cardiovasc. Res. 41, 514.
39. Lohmann, S.M., R. Fischmeister, and U. Walter. 1991. Signal transduction by cGMP in heart [Editorial]. Basic Res. Cardiol. 816, 503.
40. Beavo, J.A. 1995. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75. 725.
41. Jiang, L.H., D.J. Gawler, N. Hodson, C.J. Milligan, H.A. Pearson, V. Porter, and D. Wray. 2000. Regulation of cloned cardiac L-type calcium channels by cGMP-depen-dent protein kinase. J. Biol. Chem. 275, 6135.
42. 2+ current in single heart cells. Nature. 323, 273.
43. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc. Natl. Acad. Sci. USA. 88, 1197.
44. 2+ in intact cardiac myocytes. Circ. Res. 74, 970.
45. Shah, A.M. and P.A. MacCarthy. 2000. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol. Ther. 86, 49.
46. Kojda, G., K. Kottenberg, P. Nix, K.D. Schluter, H.M. Piper, and E. Noack. 1996. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ. Res. 78, 91.
47. Joe, E.K., A.E. Schussheim, D. Longrois, T. Maki, R.A. Kelly, T.W. Smith, and J.L. Balligand. 1998. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): mechanisms of contractile depression by nitric oxide. J. Mol. Cell Cardiol. 30, 303.
48. Balligand, J.L. and Cannon P.J. 2000. Nitric oxide and cardiomyocyte function. In Nitric Oxide and the Cardiovascular System. Loscalzo, J. and Vita, J.A., Eds. Humana Press, Totowa, NJ, p. 153.
49. Katz, A.M. Physiology of the Heart. 2001. Lippincott Williams & Wilkins, New York, p. 151.
50. Kelly, R.A., J.L. Balligand, and T.W. Smith. 1996. Nitric oxide and cardiac function. Circ. Res. 79, 363.
51. Heunks, L.M., H.A. Machiels, P.N. Dekhuijzen, Y.S. Prakash, and G.C. Sieck. 2001. Nitric oxide affects sarcoplasmic calcium release in skeletal myotubes. J. Appl. Physiol. 91, 2117.
52. Zahradnikova, A., I. Minarovic, R.C. Venema, and L.G. Meszaros. 1997. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calc. 22, 447.
53. Meszaros, L.G., I. Minarovic, and A. Zahradnikova. 1996. Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett. 380, 49.
54. Stoyanovsky, D., T. Murphy, P.R. Anno, Y.M. Kim, and G. Salama. 1997. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calc. 21, 19.
55. 2+ release in cardiomyocytes. Nat. Cell Biol. 3, 867.
56. Hart, J.D. and A.F. Dulhunty. 2000. Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. J. Membrane Biol. 173, 227.
57. Suko, J., H. Drobny, and G. Hellmann. 1999. Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings. Biochim. Biophys. Acta. 1451, 271.
58. Yoshida, A., M. Takahashi, T. Imagawa, M. Shigekawa, H. Takisawa, and T. Nakamura. 1992. Phosphorylation of ryanodine receptors in rat myocytes during beta-adrenergic stimulation. J. Biochem. (Tokyo) 111, 186.
59. Stamler, J.S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 78, 931.
60. Laurent, M., M. Lepoivre, and J.P. Tenu. 1996. Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase. Biochem. J. 314 (Part 1), 109.
61. Simonsen, U., R.M. Wadsworth, N.H. Buus, and M.J. Mulvany. 1999. In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. J. Physiol. 516 (Part 1), 271.
62. 2+ channels by S-nitrosothiol nitric oxide donors. Circ. Res. 81, 742.
63. Khandoudi, N., J. Percevault-Albadine, and A. Bril. 1998. Consequences of the inhibition of the sarcoplasmic reticulum calcium ATPase on cardiac function and coronary flow in rabbit isolated perfused heart: role of calcium and nitric oxide. J. Mol. Cell Cardiol. 30, 1967.
64. 2+ ATPase in skeletal muscle. Biochem. J. 340 (Part 3), 657.
65. Viner, R.I., T.D. Williams, and C. Schoneich. 2000. Nitric oxide-dependent modification of the sarcoplasmic reticulum Ca-ATPase: localization of cysteine target sites. Free Radic. Biol. Med. 29, 489.
66. Larsson, L. and T. Ansved. 1995. Effects of ageing on the motor unit. Progr. Neuro-biol. 45, 397.
67. Larsson, L. and G. Salviati. 1989. Effects of age on calcium transport activity of sarcoplasmic reticulum in fast- and slow-twitch rat muscle fibres. J. Physiol. 419, 253.
68. Viner, R.I., D.A. Ferrington, A.F. Huhmer, D.J. Bigelow, and C. Schoneich. 1996. Accumulation of nitrotyrosine on the SERCA 2a isoform of SR Ca ATPase of rat skeletal muscle during aging: a peroxynitrite-mediated process? FEBS Lett. 379, 286.
69. Gath, I., E.I. Closs, U. Godtel-Armbrust, S. Schmitt, M. Nakane, I. Wessler, and U. Forstermann. 1996. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J. 10, 1614.
70. Eisner, D.A., H.S. Choi, M.E. Diaz, S.C. O'Neill, and A.W. Trafford. 2000. Integrative analysis of calcium cycling in cardiac muscle. Circ. Res. 87, 1087.
71. Neumann, J., R. Maas, P. Boknik, L.R. Jones, N. Zimmermann, and H. Scholz. 1999. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts. J. Pharmacol. Exp. Ther. 289, 188.
72. Brittsan, A.G. and E.G. Kranias. 2000. Phospholamban and cardiac contractile function. J. Mol. Cell Cardiol. 32, 2131.
73. Kranias, E.G. and J. Di Salvo. 1986. A phospholamban protein phosphatase activity associated with cardiac sarcoplasmic reticulum. J. Biol. Chem. 261, 10029.
74. Ahmad, Z., F.J. Green, H.S. Subuhi, and A.M. Watanabe. 1989. Autonomic regulation of type 1 protein phosphatase in cardiac muscle. J. Biol. Chem. 264, 3859.
75. 2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ. Res. 73, 1128.
76. Moreno, H., D.M. Vega-Saenz, M.S. Nadal, Y. Amarillo, and B. Rudy. 2001. Modulation of Kv3 potassium channels expressed in CHO cells by a nitric oxide-activated phosphatase. J. Physiol. 530, 345.
77. Clementi, E., G.C. Brown, M. Feelisch, and S. Moncada. 1998. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc. Natl. Acad. Sci. USA. 95, 7631.
78. Brookes, P.S., J. Zhang, L. Dai, F. Zhou, D.A. Parks, V.M. Darley-Usmar, and P.G. Anderson. 2001. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J. Mol. Cell Cardiol. 33, 69.
79. Kaasik, A., A. Minajeva, E. De Sousa, R. Ventura-Clapier, and V. Veksler. 1999. Nitric oxide inhibits cardiac energy production via inhibition of mitochondrial creatine kinase. FEBS Lett. 444, 75.
80. Gross, W.L., M.I. Bak, J.S. Ingwall, M.A. Arstall, T.W. Smith, J.L. Balligand, and R.A. Kelly. 1996. Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve. Proc. Natl. Acad. Sci. USA. 93, 5604.
81. Xie, Y.W., P.M. Kaminski, and M.S. Wolin. 1998. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ. Res. 82, 891.
82. Beckman, J.S. and W.H. Koppenol. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424.
83. Packer, M.A., C.M. Porteous, and M.P. Murphy. 1996. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem. Mol. Biol. Int. 40, 527.
84. Packer, M.A., J.L. Scarlett, S.W. Martin, and M.P. Murphy. 1997. Induction of the mitochondrial permeability transition by peroxynitrite. Biochem. Soc. Trans. 25, 909.
85. Gunter, T.E., K.K. Gunter, S.S. Sheu, and C.E. Gavin. 1994. Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 267, C313.
86. Richter, C., V. Gogvadze, R. Schlapbach, M. Schweizer, and J. Schlegel. 1994. Nitric oxide kills hepatocytes by mobilizing mitochondrial calcium. Biochem. Biophys. Res. Commun. 205, 1143.
87. Scarlett, J.L., M.A. Packer, C.M. Porteous, and M.P. Murphy. 1996. Alterations to glutathione and nicotinamide nucleotides during the mitochondrial permeability transition induced by peroxynitrite. Biochem. Pharmacol. 52, 1047.
88. 2+ release from intact rat liver mitochondria. Biochemistry. 35, 4524.
89. Packer, M.A. and M.P. Murphy. 1995. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur. J. Biochem. 234, 231.
90. Balakirev, M.Y., V.V. Khramtsov, and G. Zimmer. 1997. Modulation of the mitochondrial permeability transition by nitric oxide. Eur. J. Biochem. 246, 710.
91. Kantrow, S.P. and C.A. Piantadosi. 1997. Release of cytochrome C from liver mitochondria during permeability transition. Biochem. Biophys. Res. Commun. 232, 669.
92. Hortelano, S., B. Dallaporta, N. Zamzami, T. Hirsch, S. A. Susin, I. Marzo, L. Bosca, and G. Kroemer. 1997. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett. 410, 373.
93. Bonfoco, E., D. Krainc, M. Ankarcrona, P. Nicotera, and S.A. Lipton. 1995. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA. 92, 7162.
94. Wink, D.A., K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, T.M. Dunams, T.A. Cebula, W.H. Koch, A.W. Andrews, J.S. Allen. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254, 1001.
95. Zhang, J., V.L. Dawson, T.M. Dawson, and S.H. Snyder. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263, 687.
96. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell. 88, 323.
97. Eliasson, M.J., K. Sampei, A.S. Mandir, P.D. Hum, R.J. Traystman, J. Bao, A. Pieper, Z.Q. Wang, T.M. Dawson, S.H. Snyder, and V.L. Dawson. 1997. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3, 1089.
98. Szabo, C., B. Zingarelli, M. O'Connor, and A.L. Salzman. 1996. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA. 93, 1753.
99. Virag, L., G.S. Scott, S. Cuzzocrea, D. Marmer, A.L. Salzman, and C. Szabo. 1998. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology. 94, 345.
100. Lakatta, E.G. 1999. Cardiovascular aging research: the next horizons. J. Am. Geriatr. Soc. 47, 613.
101. Chung, M.K., T.S. Gulick, R.E. Rotondo, G.F. Schreiner, and L.G. Lange. 1990. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ. Res. 67, 753.
102. Balligand, J.L., D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T.W. Smith. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91, 2314.
103. Balligand, J.L. 1999. Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc. Res. 43, 607.
104. Ungureanu-Longrois, D., J.L. Balligand, I. Okada, W.W. Simmons, L. Kobzik, C.J. Lowenstein, S.L. Kunkel, T. Michel, R.A. Kelly, and T.W. Smith. 1995. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ. Res. 77, 486.
105. 2+ in cardiac myocytes. Circ. Res. 81, 1011.
106. Gealekman, O., Z. Abassi, I. Rubinstein, J. Winaver, and O. Binah. 2002. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation. 105, 236.
107. Funakoshi, H., T. Kubota, N. Kawamura, Y. Machida, A. M. Feldman, H. Tsutsui, H. Shimokawa, and A. Takeshita. 2002. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ. Res. 90, 959.
108. Flesch, M., H. Kilter, B. Cremers, O. Lenz, M. Sudkamp, F. Kuhn-Regnier, and M. Bohm. 1997. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J. Pharmacol. Exp. Ther. 281, 1340.
109. Han, X., Y. Shimoni, and W.R. Giles. 1995. A cellular mechanism for nitric oxidemediated cholinergic control of mammalian heart rate. J. Gen. Physiol. 106, 45.
110. Gauthier, C., V. Leblais, L. Kobzik, J.N. Trochu, N. Khandoudi, A. Bril, J.L. Balli-gand, and H. Le Marec. 1998. The negative inotropic effect of beta-3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 102, 1377.
111. Sulakhe, P.V., L. Sandirasegarane, J.P. Davis, X.T. Vo, W.J. Costain, and R.R. Mainra. 1996. Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes. Mol. Cell Biochem. 163, 305.